GPC3 and metabolic dysfunction-associated steatotic liver disease: These results are in line with clinical data showing that GPC3 is a very specific hepatic tumor marker that is not expressed in healthy liver tissue and remains absent in liver pathologies such as NAFLD or cirrhosis [37].